30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

2014 Revenue: DePuy Synthes/Johnson & Johnson

2014 revenue $9,675MM, +3% (U.S. $5,197MM, +2%; ex-U.S. $4,478MM, +4%)

  • Hips +4%
  • Knees +3%
  • Trauma +5%
  • Beginning to realize benefits of scale/breadth, strategic wins in key markets, from combined businesses

 

4Q14 revenue $2,441MM, +3% (U.S. $1,339MM, +2%; ex-U.S. $1,102MM, +3%)

  • Hips +5%
  • Knees +3%
  • Spine +3%
  • Trauma +1%
  • Price pressure across all major categories
  • Hips and knees supported by primary stem platform, ATTUNE knee; price pressure offset by positive mix
  • Double-digit sports medicine growth, driven by MONOVISC launch and continued strong ORTHOVISC sales
  • Solid market volume growth in spine, new product launches partially offset by price pressure